Actionable news
0
All posts from Actionable news
Actionable news in AGTC: APPLIED GENETIC TECHNOLOGIES CORPORATION,

Applied Genetic Technology Tumbles 32% On Eye Study Problems

On Tuesday, Applied Genetic Technology (AGTC) tumbled 32% after reporting problems with its gene trial in treating patients with a rare eye disorder. The company even reported earnings for the fiscal fourth quarter, and those earnings were mixed. The stock is not being punished for its mixed earnings report. Most pharmaceutical companies in the clinical stage of testing don't generate revenue, therefore investors are more concerned about the trials themselves.

This is where the fall of 32% in the AGTC stock comes in. The reason for the fall is that there were a few problems with the clinical trials that the company is...


More